These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17466669)

  • 1. The risk of a major trisomy in fetuses with pyelectasis: the impact of an abnormal maternal serum screen or additional sonographic markers.
    Bornstein E; Barnhard Y; Donnenfeld AE; Ferber A; Divon MY
    Am J Obstet Gynecol; 2007 May; 196(5):e24-6. PubMed ID: 17466669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal pyelectasis: does fetal gender modify the risk of major trisomies?
    Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY
    Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic scoring index for prenatal detection of chromosomal abnormalities.
    Benacerraf BR; Neuberg D; Bromley B; Frigoletto FD
    J Ultrasound Med; 1992 Sep; 11(9):449-58. PubMed ID: 1283415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal sonographic findings in trisomy 13, 18, 21 and 22. A review of 46 cases.
    Seoud MA; Alley DC; Smith DL; Levy DL
    J Reprod Med; 1994 Oct; 39(10):781-7. PubMed ID: 7837124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatally detectable markers for the diagnosis of autosomally trisomic fetuses in at-risk pregnancies.
    Salihu HM; Boos R; Schmidt W
    Am J Perinatol; 1997 May; 14(5):257-61. PubMed ID: 9259939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21.
    Vintzileos AM; Campbell WA; Rodis JF; Guzman ER; Smulian JC; Knuppel RA
    Obstet Gynecol; 1996 Jun; 87(6):948-52. PubMed ID: 8649704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of sonographic markers of fetal aneuploidy depends on maternal and fetal characteristics.
    Taslimi MM; Acosta R; Chueh J; Hudgins L; Hunter K; Druzin ML; Chitkara U
    J Ultrasound Med; 2005 Jun; 24(6):811-5. PubMed ID: 15914685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted?
    Corteville JE; Dicke JM; Crane JP
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):770-2. PubMed ID: 1533023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of gestational age on the sonographic detection of aneuploidy.
    Picklesimer AH; Moise KJ; Wolfe HM
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1243-7. PubMed ID: 16157145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated fetal pyelectasis and chromosomal abnormalities.
    Coco C; Jeanty P
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):732-8. PubMed ID: 16150267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography.
    Vintzileos AM; Egan JF
    Am J Obstet Gynecol; 1995 Mar; 172(3):837-44. PubMed ID: 7892872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester ultrasound screening for chromosomal abnormalities.
    Shipp TD; Benacerraf BR
    Prenat Diagn; 2002 Apr; 22(4):296-307. PubMed ID: 11981910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated mild fetal pyelectasis detected by transvaginal sonography in advanced maternal age.
    Guariglia L; Rosati P
    Obstet Gynecol; 1998 Nov; 92(5):833-6. PubMed ID: 9794678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic markers of fetal trisomies: second trimester.
    Nyberg DA; Souter VL
    J Ultrasound Med; 2001 Jun; 20(6):655-74. PubMed ID: 11400940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trisomies and other chromosome abnormalities detected after positive sonographic findings.
    Beke A; Papp C; Tóth-Pál E; Mezei G; Joó JG; Csaba A; Papp Z
    J Reprod Med; 2005 Sep; 50(9):675-91. PubMed ID: 16363756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal sonographic findings in 207 fetuses with trisomy 21.
    Papp C; Bán Z; Szigeti Z; Csaba A; Lázár L; Nagy GR; Papp Z
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):186-90. PubMed ID: 17029755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal sonographic markers of trisomy 21.
    Tongsong T; Wanapirak C; Sirichotiyakul S; Sirivatanapa P
    J Med Assoc Thai; 2001 Feb; 84(2):274-80. PubMed ID: 11336089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormality.
    Wickstrom EA; Thangavelu M; Parilla BV; Tamura RK; Sabbagha RE
    Obstet Gynecol; 1996 Sep; 88(3):379-82. PubMed ID: 8752243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the risk for aneuploidy in fetuses with isolated pyelectasis.
    Carbone JF; Tuuli MG; Dicke JM; Macones GA; Odibo AO
    Prenat Diagn; 2011 Jun; 31(6):566-70. PubMed ID: 21442628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.